GIC looks to PE to drive returns amid rising inflation
Singapore’s GIC is increasing its private equity allocation as part of a broader alternatives-oriented effort to ensure that returns keep pace with elevated inflation.
The sovereign wealth fund, which claims to have invested well over USD 100bn while independent assessments put its wealth at more than USD 300bn, had 17% of its assets in private equity as of March 2022,...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.